Companies: 10,795·Total market cap: $144.5T
BioPlus Acquisition Corp.

BioPlus Acquisition Corp.

BIOSNASDAQFinancial Services
$10.80
$-0.01(-0.05%)
Market Cap$209072163
P/E Ratio
52W High$11.68
52W Low$10.12
Overview

BioPlus Acquisition Corp. (BIOS) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · BIOS · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

BioPlus Acquisition Corp. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

BIOS insider buying and selling by quarter

BIOS insider selling · BIOS insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
380K190K0
2010 Q2
2017 Q3
2021 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

BIOS executive sell shares · BIOS board member insider trading · BIOS insider trading SEC filing

Showing 8 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Coliseum Capital Management, LLC

Director · 10% Owner

Option

Date

Aug 6

Shares

18,905

Price

Value

View Form 4 on SEC.gov

Coliseum Capital Management, LLC

Director · 10% Owner

Award

Date

Aug 6

Shares

1,549,321

Price

$0.00

Value

$155

View Form 4 on SEC.gov

Coliseum Capital Management, LLC

Director · 10% Owner

Other

Date

Aug 6

Shares

18,905

Price

$2.67

Value

$50K

View Form 4 on SEC.gov

Coliseum Capital Management, LLC

Director · 10% Owner

Award

Date

Aug 6

Shares

27,300

Price

$2143221.10

Value

$58.51B ⚡

View Form 4 on SEC.gov

Coliseum Capital Management, LLC

Director

Option

Date

Jun 10

Shares

43,726

Price

Value

View Form 4 on SEC.gov

Coliseum Capital Management, LLC

Director

Other

Date

Jun 10

Shares

43,726

Price

$2.19

Value

$96K

View Form 4 on SEC.gov

Coliseum Capital Management, LLC

Director

Option

Date

May 2

Shares

49,669

Price

Value

View Form 4 on SEC.gov

Coliseum Capital Management, LLC

Director

Other

Date

May 2

Shares

49,669

Price

$2.69

Value

$134K

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About BIOS insider trading

BIOS insider trades

BioPlus Acquisition Corp. (BIOS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including BIOS. Over the past 12 months, 0 insiders have filed transactions with the SEC. BIOS insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For BioPlus Acquisition Corp.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

BIOS insider trading · 5 questions

The insiders of BioPlus Acquisition Corp. (BIOS) include executives and directors such as BIOS, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

BIOS board member insider tradingwho are BIOS insidersBIOS insider rosterBioPlus Acquisition Corp. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026